Incorporating noncanonical amino acids into peptide hydrogels improves their stability, biocompatibility, and drug-delivery properties.
Smart hydrogelsncAA-containing peptides form tunable, biocompatible hydrogels for advanced biomedical applications
What the researchers found
Noncanonical amino acids in peptide hydrogels modulate physicochemical properties, enhancing stability, biocompatibility, and functionality for biomedical use.
Why it matters
Better hydrogels mean better drug delivery — ncAAs overcome stability limitations that have held back peptide-based therapeutics.
The numbers in context
No specific clinical data; reviews chemical and materials science literature on ncAA-based hydrogels.
How the study worked
Keynote review of chemical and biocatalytic synthesis approaches for ncAA-containing peptide hydrogels.
Who was studied
N/A
What this study cannot tell us
Review focuses on design principles — most applications are preclinical with limited clinical translation data.
How to read the evidence
Review of materials science and chemistry research — strong design rationale but mostly preclinical applications.
When this study was published
Published in 2025, reflecting cutting-edge advances in peptide biomaterials.
The bigger picture
This represents the convergence of synthetic chemistry and biomaterials, creating a new generation of programmable drug delivery systems.
Questions still open
- Which ncAA modifications provide the best balance of stability and biocompatibility?
- How close are ncAA hydrogels to clinical application?
Common questions
What are noncanonical amino acids?
What are peptide hydrogels used for?
Read the original research
Engineered noncanonical amino acids-based hydrogels for biomedical applications.
Drug discovery today, 30(7), 104398
Citation
Pophali, Salil; Shrivastava, Vidit; Misra, Rajkumar; Jain, Rahul. (2025). Engineered noncanonical amino acids-based hydrogels for biomedical applications.. Drug discovery today, 30(7), 104398. https://doi.org/10.1016/j.drudis.2025.104398